首页 > 最新文献

Revista de Gastroenterologia de Mexico最新文献

英文 中文
Utilidad del bevacizumab en sangrado gastrointestinal crónico en telangiectasia hemorrágica hereditaria 贝伐单抗在遗传性出血性毛细血管扩张中的慢性胃肠道出血中的应用
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2023.04.005
A. Gutiérrez-Macías, I. Barroso-Benayos, A. Burzako-Sánchez
{"title":"Utilidad del bevacizumab en sangrado gastrointestinal crónico en telangiectasia hemorrágica hereditaria","authors":"A. Gutiérrez-Macías, I. Barroso-Benayos, A. Burzako-Sánchez","doi":"10.1016/j.rgmx.2023.04.005","DOIUrl":"10.1016/j.rgmx.2023.04.005","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S037509062300054X/pdfft?md5=8cab213da7fea6a2b3c1f88ec0a2ceb4&pid=1-s2.0-S037509062300054X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47365483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El método de evaluación de causalidad de hepatotoxicidad de Roussel-Uclaf en el contexto de sospecha diagnóstica de daño hepático inducido por medicamentos: ¿es aún vigente? 罗塞尔-乌克拉夫肝毒性因果关系评估法在诊断怀疑药物性肝损伤方面是否仍然有效?
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2023.04.008
C.B. Sánchez Luque
{"title":"El método de evaluación de causalidad de hepatotoxicidad de Roussel-Uclaf en el contexto de sospecha diagnóstica de daño hepático inducido por medicamentos: ¿es aún vigente?","authors":"C.B. Sánchez Luque","doi":"10.1016/j.rgmx.2023.04.008","DOIUrl":"https://doi.org/10.1016/j.rgmx.2023.04.008","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090623000897/pdfft?md5=7aaa834cf61a28df80b3321bebddeb7f&pid=1-s2.0-S0375090623000897-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto en la incidencia de perforación gastrointestinal durante la pandemia de COVID-19 en el área sanitaria Costa del Sol 太阳海岸卫生区 COVID-19 大流行期间对肠胃穿孔发病率的影响。
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2022.02.004
A.M. Mudarra Vela , F. Rivas Ruiz , J. Atienza Carrasco , F.J. Medina Cano

Introduction and aims

Gastrointestinal perforation is a surgical emergency that is associated with a high mortality rate and requires special care. During the pandemic, there has been competition with COVID-19 patients for health resources, especially ICU bed availability. The primary aim of our study was to compare the incidence of gastrointestinal perforation during the COVID-19 pandemic, with cases registered before the pandemic.

Materials and methods

A retrospective, observational, single center, cohort study was conducted that included patients that underwent emergency surgery for gastrointestinal perforation in the periods during the pandemic (6 months) and before the pandemic (12 months). Sociodemographic characteristics, comorbidities, duration of hospital and ICU stay, status at discharge, and perforation site were compared.

Results

The study included 67 subjects (33 in the pre-pandemic period and 34 in the pandemic period). There were no significant differences regarding sex, age, or comorbidity. The perforation rate per emergency intervention was 4-times higher during the pandemic. There was an increase in the number of patients that were foreigners (4 [11%]) and nonresidents (6 [17%]). ICU admissions decreased (6 [19%]) but ICU stay increased to 137 h. Hospital stay increased by 5 days and delay in care increased 4.5 h. The number of deaths was higher (from 5 [15.2%] to 10 [29.4%]). Four patients with perforations were positive for COVID-19, were admitted to the ICU, and died.

Conclusions

During the COVID-19 pandemic there was an increase in the incidence of gastrointestinal perforations at our healthcare system area; symptoms were more advanced, and mortality was higher.

导言和目的胃肠道穿孔是一种外科急症,死亡率高,需要特殊护理。在大流行期间,COVID-19 患者争夺医疗资源,尤其是重症监护室床位。我们研究的主要目的是比较 COVID-19 大流行期间和大流行前登记的胃肠道穿孔病例的发病率。材料和方法 我们开展了一项回顾性、观察性、单中心、队列研究,纳入了在大流行期间(6 个月)和大流行前(12 个月)因胃肠道穿孔接受急诊手术的患者。研究比较了患者的社会人口学特征、合并症、住院时间和重症监护室住院时间、出院时的状况以及穿孔部位。性别、年龄或合并症方面没有明显差异。在大流行期间,每次紧急干预的穿孔率要高出 4 倍。外国人(4 [11%])和非本地居民(6 [17%])患者的人数有所增加。入住重症监护室的人数有所减少(6 [19%]),但重症监护室的住院时间增加到 137 小时。结论在 COVID-19 大流行期间,我们医疗系统所在地区的胃肠道穿孔发生率增加;症状更加严重,死亡率更高。
{"title":"Impacto en la incidencia de perforación gastrointestinal durante la pandemia de COVID-19 en el área sanitaria Costa del Sol","authors":"A.M. Mudarra Vela ,&nbsp;F. Rivas Ruiz ,&nbsp;J. Atienza Carrasco ,&nbsp;F.J. Medina Cano","doi":"10.1016/j.rgmx.2022.02.004","DOIUrl":"10.1016/j.rgmx.2022.02.004","url":null,"abstract":"<div><h3>Introduction and aims</h3><p>Gastrointestinal perforation is a surgical emergency that is associated with a high mortality rate and requires special care. During the pandemic, there has been competition with COVID-19 patients for health resources, especially ICU bed availability. The primary aim of our study was to compare the incidence of gastrointestinal perforation during the COVID-19 pandemic, with cases registered before the pandemic.</p></div><div><h3>Materials and methods</h3><p>A retrospective, observational, single center, cohort study was conducted that included patients that underwent emergency surgery for gastrointestinal perforation in the periods during the pandemic (6 months) and before the pandemic (12 months). Sociodemographic characteristics, comorbidities, duration of hospital and ICU stay, status at discharge, and perforation site were compared.</p></div><div><h3>Results</h3><p>The study included 67 subjects (33 in the pre-pandemic period and 34 in the pandemic period). There were no significant differences regarding sex, age, or comorbidity. The perforation rate per emergency intervention was 4-times higher during the pandemic. There was an increase in the number of patients that were foreigners (4 [11%]) and nonresidents (6 [17%]). ICU admissions decreased (6 [19%]) but ICU stay increased to 137<!--> <!-->h. Hospital stay increased by 5 days and delay in care increased 4.5<!--> <!-->h. The number of deaths was higher (from 5 [15.2%] to 10 [29.4%]). Four patients with perforations were positive for COVID-19, were admitted to the ICU, and died.</p></div><div><h3>Conclusions</h3><p>During the COVID-19 pandemic there was an increase in the incidence of gastrointestinal perforations at our healthcare system area; symptoms were more advanced, and mortality was higher.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090622000465/pdfft?md5=b79082829d592511f2ea93e61285a5c0&pid=1-s2.0-S0375090622000465-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80651084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adherencia a la dieta sin gluten en celíacos del Paraguay 巴拉圭坚持无麸质饮食
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2021.10.009
R.E. Real-Delor , M.E. Chamorro-Aguilera

Introduction and aim

The treatment for celiac disease is a gluten-free diet that should be strictly and permanently carried out. Our aims were to determine adherence to the gluten-free diet and the risk factors for non-adherence.

Materials and methods

An observational, cross-sectional, comparative study was conducted. It included individuals of both sexes and of any age that presented with celiac disease, lived in Paraguay from January to April 2021, and agreed to participate in the survey. Incomplete questionnaires were excluded. Non-probabilistic convenience sampling was utilized. Adherence was measured using the Leffler questionnaire. The study was approved by the Ethics Committee of the Universidad Privada del Este.

Results

The sample consisted of 371 respondents, 322 (87%) of whom were adults, with a mean age of 38±12 years, and 49 (13%) of whom were children and adolescents, with a mean age of 10±5 years. Female sex was predominant (85%). Adherence to the gluten-free diet was detected in 59% of the adults and 73% of the children and adolescents. The factors significantly associated with adherence included belonging to the child and adolescent age group and having had the diagnosis for a longer time: 9±8 years for the adherence group and 7±8 years for the non-adherence group.

Conclusions

The present study demonstrated the frequency of adherence to the gluten-free diet in celiac patients in Paraguay. Psychologic and nutritional support is recommended for individuals with celiac disease that do not adhere to their treatment.

导言和目的乳糜泻的治疗方法是无麸质饮食,应严格并长期执行。我们的目的是确定无麸质饮食的依从性以及不依从的风险因素。研究对象包括患有乳糜泻、2021 年 1 月至 4 月期间居住在巴拉圭并同意参与调查的男女老少。不包括不完整的问卷。采用非概率方便抽样。采用勒弗勒问卷对依从性进行测量。研究获得了埃斯特私立大学伦理委员会的批准。结果样本由 371 名受访者组成,其中 322 人(87%)为成年人,平均年龄为(38±12)岁;49 人(13%)为儿童和青少年,平均年龄为(10±5)岁。女性占多数(85%)。59%的成人和 73% 的儿童和青少年坚持无麸质饮食。与坚持饮食明显相关的因素包括属于儿童和青少年年龄组以及确诊时间较长:坚持饮食组为 9±8 年,不坚持饮食组为 7±8 年。建议为不坚持治疗的乳糜泻患者提供心理和营养支持。
{"title":"Adherencia a la dieta sin gluten en celíacos del Paraguay","authors":"R.E. Real-Delor ,&nbsp;M.E. Chamorro-Aguilera","doi":"10.1016/j.rgmx.2021.10.009","DOIUrl":"10.1016/j.rgmx.2021.10.009","url":null,"abstract":"<div><h3>Introduction and aim</h3><p>The treatment for celiac disease is a gluten-free diet that should be strictly and permanently carried out. Our aims were to determine adherence to the gluten-free diet and the risk factors for non-adherence.</p></div><div><h3>Materials and methods</h3><p>An observational, cross-sectional, comparative study was conducted. It included individuals of both sexes and of any age that presented with celiac disease, lived in Paraguay from January to April 2021, and agreed to participate in the survey. Incomplete questionnaires were excluded. Non-probabilistic convenience sampling was utilized. Adherence was measured using the Leffler questionnaire. The study was approved by the Ethics Committee of the <em>Universidad Privada del Este</em>.</p></div><div><h3>Results</h3><p>The sample consisted of 371 respondents, 322 (87%) of whom were adults, with a mean age of 38±12 years, and 49 (13%) of whom were children and adolescents, with a mean age of 10±5 years. Female sex was predominant (85%). Adherence to the gluten-free diet was detected in 59% of the adults and 73% of the children and adolescents. The factors significantly associated with adherence included belonging to the child and adolescent age group and having had the diagnosis for a longer time: 9±8 years for the adherence group and 7±8 years for the non-adherence group.</p></div><div><h3>Conclusions</h3><p>The present study demonstrated the frequency of adherence to the gluten-free diet in celiac patients in Paraguay. Psychologic and nutritional support is recommended for individuals with celiac disease that do not adhere to their treatment.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090622000519/pdfft?md5=480ff70f1f96c4c07c9538f8eb7a175e&pid=1-s2.0-S0375090622000519-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47306602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Uso de dispositivos audiovisuales en endoscopia transnasal sin sedación con el objetivo de mejorar la tolerancia. Estudio clínico prospectivo 在没有镇静的情况下在经鼻内窥镜检查中使用视听设备,以提高耐受性。前瞻性临床研究
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2021.11.012
J.A. González-González , D.E. Benavides-Salgado , D. Garcia-Compean , B. González-Gómez , J.M. Muñoz-Ayala , R.A. Jiménez-Castillo , H.R. Ibarra-Sifuentes , A. Atilano-Díaz , J. Sordia-Ramírez , M.D. Ramos-Cuevas , H.J. Maldonado-Garza

Introduction and objective

Transnasal endoscopy (TNE) has proven its diagnostic utility, but it has not been widely accepted given that it is performed without sedation. There are no previous studies on the use of methods to improve its tolerability. Our aim was to evaluate the tolerability of TNE, when simultaneously performed with an audiovisual device as a distractor.

Methods

We evaluated 50 patients, 10 of whom did not agree to participate. The performance of the procedure was explained, using an audiovisual device. Before randomization, we applied anxiety and depression scores. Patients were divided into 2 groups: Group I (using an audiovisual device during the procedure) and Group II (without a device). Anxiety and numeric pain rating scales were used, and vital signs were monitored and recorded before, during, and after the endoscopy. An overall procedure satisfaction score was applied at the end of the study and 24 h later.

Results

Mean age was 41.6 years and 35 of the patients were women (87.5%). The most frequent indication for TNE was refractory gastroesophageal reflux disease. There were no severe comorbidities, and none of the patients had a significant anxiety or depression score. One patient in Group II did not tolerate TNE due to nasal pain. There was no statistically significant difference between groups, regarding anxiety, pain, vital signs, and satisfaction scale.

Conclusion

Our study showed that TNE was well tolerated and had a high acceptance rate in our patients. The use of distracting audiovisual devices did not increase tolerance to the endoscopic procedure.

导言和目的经鼻内窥镜检查(TNE)已被证明具有诊断作用,但由于其无需镇静剂,因此尚未被广泛接受。目前还没有关于如何提高其耐受性的研究。我们的目的是评估 TNE 同时使用视听设备分散注意力时的耐受性。我们使用视听设备解释了操作过程。随机分组前,我们对患者进行了焦虑和抑郁评分。患者被分为两组:第一组(手术过程中使用视听设备)和第二组(不使用视听设备)。我们使用了焦虑和数字疼痛评分量表,并在内窥镜检查之前、期间和之后监测和记录了生命体征。研究结束时和 24 小时后,对手术的总体满意度进行评分。结果 平均年龄为 41.6 岁,35 名患者为女性(87.5%)。TNE最常见的适应症是难治性胃食管反流病。患者没有严重的合并症,也没有明显的焦虑或抑郁症状。第二组中有一名患者因鼻腔疼痛而无法忍受 TNE。在焦虑、疼痛、生命体征和满意度量表方面,组间差异无统计学意义。使用分散注意力的视听设备并不会增加患者对内窥镜手术的耐受性。
{"title":"Uso de dispositivos audiovisuales en endoscopia transnasal sin sedación con el objetivo de mejorar la tolerancia. Estudio clínico prospectivo","authors":"J.A. González-González ,&nbsp;D.E. Benavides-Salgado ,&nbsp;D. Garcia-Compean ,&nbsp;B. González-Gómez ,&nbsp;J.M. Muñoz-Ayala ,&nbsp;R.A. Jiménez-Castillo ,&nbsp;H.R. Ibarra-Sifuentes ,&nbsp;A. Atilano-Díaz ,&nbsp;J. Sordia-Ramírez ,&nbsp;M.D. Ramos-Cuevas ,&nbsp;H.J. Maldonado-Garza","doi":"10.1016/j.rgmx.2021.11.012","DOIUrl":"10.1016/j.rgmx.2021.11.012","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>Transnasal endoscopy (TNE) has proven its diagnostic utility, but it has not been widely accepted given that it is performed without sedation. There are no previous studies on the use of methods to improve its tolerability. Our aim was to evaluate the tolerability of TNE, when simultaneously performed with an audiovisual device as a distractor.</p></div><div><h3>Methods</h3><p>We evaluated 50 patients, 10 of whom did not agree to participate. The performance of the procedure was explained, using an audiovisual device. Before randomization, we applied anxiety and depression scores. Patients were divided into 2 groups: Group I (using an audiovisual device during the procedure) and Group II (without a device). Anxiety and numeric pain rating scales were used, and vital signs were monitored and recorded before, during, and after the endoscopy. An overall procedure satisfaction score was applied at the end of the study and 24<!--> <!-->h later.</p></div><div><h3>Results</h3><p>Mean age was 41.6 years and 35 of the patients were women (87.5%). The most frequent indication for TNE was refractory gastroesophageal reflux disease. There were no severe comorbidities, and none of the patients had a significant anxiety or depression score. One patient in Group II did not tolerate TNE due to nasal pain. There was no statistically significant difference between groups, regarding anxiety, pain, vital signs, and satisfaction scale.</p></div><div><h3>Conclusion</h3><p>Our study showed that TNE was well tolerated and had a high acceptance rate in our patients. The use of distracting audiovisual devices did not increase tolerance to the endoscopic procedure.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090622001045/pdfft?md5=c96a4d0a4458bb2b4813742587c09f8f&pid=1-s2.0-S0375090622001045-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48686274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Los mastocitos perivasculares y la expresión de VEGF, laminina-332 y MMP-9 en neoplasias colorrectales humanas 血管周围肥大细胞与人类结直肠肿瘤中血管内皮生长因子、层粘连蛋白-332 和 MMP-9 的表达
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2022.03.011
L. Meloti-Fiorio , I. Silva-Sinara-Alves , F. Rohor-de-Souza , W. Grassi-Bautz , F. Silva-Souza-Ribeiro , L. Pinto-Nogueira-da-Gama , L. Nogueira-da-Gama-de-Souza

Introduction and objectives

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, and significantly contributes to cancer-related deaths. Most cases arise from adenomatous polyps. Biomarkers currently play an important role in tumor progression. Our aim was to identify perivascular mast cells and analyze the expression of laminin-332, MMP-9, and VEGF in cases of adenoma and CRC in humans.

Materials and methods

Patients were selected at the Coloproctology Service and samples were obtained through biopsies. Adenoma and CRC slides were examined, utilizing immunohistochemistry to detect molecules, and were processed, using 1% Alcian Blue (pH .5) for mast cell staining.

Results

Higher density of perivascular mast cells was observed in adenomas. Laminin-332 expression revealed basement membrane discontinuity associated with tumor invasion in CRC. MMP-9 immunostaining in adenoma was detected in glandular epithelium and lining epithelium, in areas close to the basement membrane, whereas in CRC, the enzyme was found in the cytoplasm of invasive clusters. VEGF expression was associated with cell atypia in adenoma and in areas of disorganization of the epithelium-connective tissue interface in CRC. VEGF has also been detected in endothelial cells from microvessels.

Conclusions

We demonstrated the different patterns of perivascular mast cells and molecular expression in colorectal neoplasms. Those analyses favor the recognition of the predisposition to the disease, or its early stage, and have the potential to define the molecular profile of the lesions.

导言和目的大肠癌(CRC)是全球发病率最高的癌症之一,也是导致癌症相关死亡的重要原因。大多数病例源于腺瘤性息肉。目前,生物标志物在肿瘤进展中发挥着重要作用。我们的目的是识别血管周围肥大细胞,并分析人类腺瘤和 CRC 病例中层粘蛋白-332、MMP-9 和血管内皮生长因子的表达。利用免疫组化技术检测腺瘤和 CRC 分子,并使用 1%阿尔新蓝(pH .5)进行肥大细胞染色。层粘连蛋白-332的表达显示基底膜不连续与CRC的肿瘤侵袭有关。腺瘤的腺上皮和衬里上皮靠近基底膜的区域检测到 MMP-9 免疫染色,而在 CRC 中,该酶存在于侵袭性团块的细胞质中。在腺瘤中,VEGF 的表达与细胞不典型性有关,而在 CRC 中,则与上皮-结缔组织界面的紊乱区域有关。结论我们证明了结直肠肿瘤中血管周围肥大细胞和分子表达的不同模式。这些分析有助于识别疾病的易感性或早期阶段,并有可能确定病变的分子特征。
{"title":"Los mastocitos perivasculares y la expresión de VEGF, laminina-332 y MMP-9 en neoplasias colorrectales humanas","authors":"L. Meloti-Fiorio ,&nbsp;I. Silva-Sinara-Alves ,&nbsp;F. Rohor-de-Souza ,&nbsp;W. Grassi-Bautz ,&nbsp;F. Silva-Souza-Ribeiro ,&nbsp;L. Pinto-Nogueira-da-Gama ,&nbsp;L. Nogueira-da-Gama-de-Souza","doi":"10.1016/j.rgmx.2022.03.011","DOIUrl":"https://doi.org/10.1016/j.rgmx.2022.03.011","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, and significantly contributes to cancer-related deaths. Most cases arise from adenomatous polyps. Biomarkers currently play an important role in tumor progression. Our aim was to identify perivascular mast cells and analyze the expression of laminin-332, MMP-9, and VEGF in cases of adenoma and CRC in humans.</p></div><div><h3>Materials and methods</h3><p>Patients were selected at the Coloproctology Service and samples were obtained through biopsies. Adenoma and CRC slides were examined, utilizing immunohistochemistry to detect molecules, and were processed, using 1% Alcian Blue (pH .5) for mast cell staining.</p></div><div><h3>Results</h3><p>Higher density of perivascular mast cells was observed in adenomas. Laminin-332 expression revealed basement membrane discontinuity associated with tumor invasion in CRC. MMP-9 immunostaining in adenoma was detected in glandular epithelium and lining epithelium, in areas close to the basement membrane, whereas in CRC, the enzyme was found in the cytoplasm of invasive clusters. VEGF expression was associated with cell atypia in adenoma and in areas of disorganization of the epithelium-connective tissue interface in CRC. VEGF has also been detected in endothelial cells from microvessels.</p></div><div><h3>Conclusions</h3><p>We demonstrated the different patterns of perivascular mast cells and molecular expression in colorectal neoplasms. Those analyses favor the recognition of the predisposition to the disease, or its early stage, and have the potential to define the molecular profile of the lesions.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090622000453/pdfft?md5=5f2abb0f708fd4d6a169dc07a6946a6a&pid=1-s2.0-S0375090622000453-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consenso mexicano sobre incontinencia fecal 墨西哥粪便失禁共识
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2023.08.003
J.M. Remes-Troche , E. Coss-Adame , K.R. García-Zermeño , O. Gómez-Escudero , M. Amieva-Balmori , P.C. Gómez-Castaños , L. Charúa-Guindic , M.E. Icaza-Chávez , A. López-Colombo , E.C. Morel-Cerda , N. Pérez y López , M.C. Rodríguez-Leal , N. Salgado-Nesme , M.T. Sánchez-Avila , L.R. Valdovinos-García , O. Vergara-Fernández , A.S. Villar-Chávez

Fecal incontinence is the involuntary passage or the incapacity to control the release of fecal matter through the anus. It is a condition that significantly impairs quality of life in those that suffer from it, given that it affects body image, self-esteem, and interferes with everyday activities, in turn, favoring social isolation. There are no guidelines or consensus in Mexico on the topic, and so the Asociación Mexicana de Gastroenterología brought together a multidisciplinary group (gastroenterologists, neurogastroenterologists, and surgeons) to carry out the «Mexican consensus on fecal incontinence» and establish useful recommendations for the medical community.

The present document presents the formulated recommendations in 35 statements. Fecal incontinence is known to be a frequent entity whose incidence increases as individuals age, but one that is under-recognized. The pathophysiology of incontinence is complex and multifactorial, and in most cases, there is more than one associated risk factor. Even though there is no diagnostic gold standard, the combination of tests that evaluate structure (endoanal ultrasound) and function (anorectal manometry) should be recommended in all cases. Treatment should also be multidisciplinary and general measures and drugs (lidamidine, loperamide) are recommended, as well as non-pharmacologic interventions, such as biofeedback therapy, in selected cases. Likewise, surgical treatment should be offered to selected patients and performed by experts.

大便失禁是指粪便通过肛门时不自主地排出或无法控制排出。大便失禁严重影响患者的生活质量,因为它会影响身体形象和自尊,干扰日常活动,进而导致社会孤立。因此,墨西哥肠胃病协会(Asociación Mexicana de Gastroenterología)召集了一个多学科小组(肠胃病学家、神经肠胃病学家和外科医生),以达成 "墨西哥粪便失禁共识",并为医学界制定有用的建议。众所周知,大便失禁是一种常见疾病,其发病率随着年龄的增长而增加,但人们对其认识不足。大便失禁的病理生理学是复杂的、多因素的,在大多数情况下,相关的风险因素不止一个。尽管目前还没有诊断的金标准,但在所有病例中都应建议结合评估结构(肛门内超声)和功能(肛门直肠测压)的检查。治疗也应是多学科的,建议采取一般措施和药物(利多脒、洛哌丁胺),并在选定病例中采取非药物干预措施,如生物反馈疗法。同样,应为特定患者提供手术治疗,并由专家实施。
{"title":"Consenso mexicano sobre incontinencia fecal","authors":"J.M. Remes-Troche ,&nbsp;E. Coss-Adame ,&nbsp;K.R. García-Zermeño ,&nbsp;O. Gómez-Escudero ,&nbsp;M. Amieva-Balmori ,&nbsp;P.C. Gómez-Castaños ,&nbsp;L. Charúa-Guindic ,&nbsp;M.E. Icaza-Chávez ,&nbsp;A. López-Colombo ,&nbsp;E.C. Morel-Cerda ,&nbsp;N. Pérez y López ,&nbsp;M.C. Rodríguez-Leal ,&nbsp;N. Salgado-Nesme ,&nbsp;M.T. Sánchez-Avila ,&nbsp;L.R. Valdovinos-García ,&nbsp;O. Vergara-Fernández ,&nbsp;A.S. Villar-Chávez","doi":"10.1016/j.rgmx.2023.08.003","DOIUrl":"https://doi.org/10.1016/j.rgmx.2023.08.003","url":null,"abstract":"<div><p>Fecal incontinence is the involuntary passage or the incapacity to control the release of fecal matter through the anus. It is a condition that significantly impairs quality of life in those that suffer from it, given that it affects body image, self-esteem, and interferes with everyday activities, in turn, favoring social isolation. There are no guidelines or consensus in Mexico on the topic, and so the <em>Asociación Mexicana de Gastroenterología</em> brought together a multidisciplinary group (gastroenterologists, neurogastroenterologists, and surgeons) to carry out the «Mexican consensus on fecal incontinence» and establish useful recommendations for the medical community.</p><p>The present document presents the formulated recommendations in 35 statements. Fecal incontinence is known to be a frequent entity whose incidence increases as individuals age, but one that is under-recognized. The pathophysiology of incontinence is complex and multifactorial, and in most cases, there is more than one associated risk factor. Even though there is no diagnostic gold standard, the combination of tests that evaluate structure (endoanal ultrasound) and function (anorectal manometry) should be recommended in all cases. Treatment should also be multidisciplinary and general measures and drugs (lidamidine, loperamide) are recommended, as well as non-pharmacologic interventions, such as biofeedback therapy, in selected cases. Likewise, surgical treatment should be offered to selected patients and performed by experts.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S037509062300085X/pdfft?md5=d378f3c4d46444475637218b0ce2aa95&pid=1-s2.0-S037509062300085X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respuesta a Phinder-Puente M.E. et al. Visión actual sobre el diagnóstico y cuidados integrales en encefalopatía hepática 对 Phinder-Puente M.E. 等人 "肝性脑病综合诊断和护理的当前观点 "的回应。
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2023.08.001
J.A. Velarde-Ruiz Velasco , J.M. Aldana-Ledesma , F. Higuera-de-la-Tijera
{"title":"Respuesta a Phinder-Puente M.E. et al. Visión actual sobre el diagnóstico y cuidados integrales en encefalopatía hepática","authors":"J.A. Velarde-Ruiz Velasco ,&nbsp;J.M. Aldana-Ledesma ,&nbsp;F. Higuera-de-la-Tijera","doi":"10.1016/j.rgmx.2023.08.001","DOIUrl":"https://doi.org/10.1016/j.rgmx.2023.08.001","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090623000824/pdfft?md5=d0e1ed08ac4222efcfaf3aba9a754510&pid=1-s2.0-S0375090623000824-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139033277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La microbiota bacteriana fecal en pacientes estreñidos previa y posterior a ocho semanas de administración diaria de Bifidobacterium infantis 35624 婴儿双歧杆菌35624每日给药8周前后便秘患者粪便细菌群
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2022.04.005
M. Amieva-Balmori , J.F. García-Mazcorro , A. Martínez-Conejo , G.A. Hernández-Ramírez , K.R. García-Zermeño , O. Rodríguez-Aguilera , M. Aja-Cadena , M. Cortes-Barradas , E.M.M. Quigley , J.M. Remes-Troche

Introduction and aim

In recent years, probiotics have been used in functional gastrointestinal disorders, including chronic constipation (CC). The effect of Bifidobacterium infantis strain 35624 on the gut microbiota of CC patients has not been previously studied.

Our aim was to analyze the fecal microbiota of constipated patients, before and after consuming a single-strain probiotic (B. infantis strain 35624).

Material and methods

We used 16S rRNA gene high-throughput sequencing to analyze the fecal microbiota of female patients (n = 13) with CC. Patients were instructed to ingest one capsule of Alflorex® (containing 1 × 109 CFUs/g B. infantis strain 35624) daily for eight weeks. Fecal samples were obtained at the baseline and end (final) of probiotic administration.

Results

Alpha diversity metrics did not differ between the baseline and final periods. The butyrate producer, Oscillospira, was the taxon most strongly correlated with amplicon sequence variants (R2 = 0.55, p < 0.0001). Except for a few bacterial taxa, there were no significant differences in relative abundance between the baseline and final periods. Beta-diversity measures also showed limited evidence for the differences between the two time periods.

Conclusions

The results suggest that the fecal bacterial microbiota remains stable in constipated women consuming a single-strain probiotic. Those findings may be helpful in better understanding probiotic functioning in patients with digestive disorders.

导言和目的近年来,益生菌已被用于治疗功能性胃肠道疾病,包括慢性便秘(CC)。我们的目的是分析便秘患者在服用单一菌株益生菌(婴儿双歧杆菌 35624 株)前后的粪便微生物群。材料和方法我们使用 16S rRNA 基因高通量测序分析了女性便秘患者(n = 13)的粪便微生物群。指导患者每天服用一粒 Alflorex®(含 1 × 109 CFUs/g 婴儿嗜血杆菌 35624 株),连续服用八周。在服用益生菌的基线期和结束期(最终期)采集粪便样本。丁酸生产者 Oscillospira 是与扩增子序列变异关系最密切的分类群(R2 = 0.55,p < 0.0001)。除少数细菌类群外,基线期和最终期的相对丰度没有显著差异。结果表明,服用单一菌株益生菌的便秘妇女的粪便细菌微生物群保持稳定。这些发现可能有助于更好地了解益生菌在消化系统疾病患者中的作用。
{"title":"La microbiota bacteriana fecal en pacientes estreñidos previa y posterior a ocho semanas de administración diaria de Bifidobacterium infantis 35624","authors":"M. Amieva-Balmori ,&nbsp;J.F. García-Mazcorro ,&nbsp;A. Martínez-Conejo ,&nbsp;G.A. Hernández-Ramírez ,&nbsp;K.R. García-Zermeño ,&nbsp;O. Rodríguez-Aguilera ,&nbsp;M. Aja-Cadena ,&nbsp;M. Cortes-Barradas ,&nbsp;E.M.M. Quigley ,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmx.2022.04.005","DOIUrl":"10.1016/j.rgmx.2022.04.005","url":null,"abstract":"<div><h3>Introduction and aim</h3><p>In recent years, probiotics have been used in functional gastrointestinal disorders, including chronic constipation (CC). The effect of <em>Bifidobacterium infantis</em> strain 35624 on the gut microbiota of CC patients has not been previously studied.</p><p>Our aim was to analyze the fecal microbiota of constipated patients, before and after consuming a single-strain probiotic (<em>B. infantis</em> strain 35624).</p></div><div><h3>Material and methods</h3><p>We used 16S rRNA gene high-throughput sequencing to analyze the fecal microbiota of female patients (n<!--> <!-->=<!--> <!-->13) with CC. Patients were instructed to ingest one capsule of Alflorex® (containing 1<!--> <!-->×<!--> <!-->10<sup>9</sup> <!-->CFUs/g <em>B. infantis</em> strain 35624) daily for eight weeks. Fecal samples were obtained at the baseline and end (final) of probiotic administration.</p></div><div><h3>Results</h3><p>Alpha diversity metrics did not differ between the baseline and final periods. The butyrate producer, <em>Oscillospira</em>, was the taxon most strongly correlated with amplicon sequence variants (R<sup>2</sup> <!-->=<!--> <!-->0.55, p<!--> <!-->&lt;<!--> <!-->0.0001). Except for a few bacterial taxa, there were no significant differences in relative abundance between the baseline and final periods. Beta-diversity measures also showed limited evidence for the differences between the two time periods.</p></div><div><h3>Conclusions</h3><p>The results suggest that the fecal bacterial microbiota remains stable in constipated women consuming a single-strain probiotic. Those findings may be helpful in better understanding probiotic functioning in patients with digestive disorders.</p></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090622000787/pdfft?md5=6b1f1baf7c690bc55843a0cea84f13a9&pid=1-s2.0-S0375090622000787-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42000783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Espiroquetosis intestinal humana como causa de diarrea crónica en un paciente VIH positivo: reporte de caso hiv阳性患者慢性腹泻的人类肠道螺旋体病:病例报告
IF 1.6 Q3 Medicine Pub Date : 2023-10-01 DOI: 10.1016/j.rgmx.2023.07.005
A.J. Chaar , J.S. Arbelaez , M.J. Vargas , R.A. Cañadas
{"title":"Espiroquetosis intestinal humana como causa de diarrea crónica en un paciente VIH positivo: reporte de caso","authors":"A.J. Chaar ,&nbsp;J.S. Arbelaez ,&nbsp;M.J. Vargas ,&nbsp;R.A. Cañadas","doi":"10.1016/j.rgmx.2023.07.005","DOIUrl":"10.1016/j.rgmx.2023.07.005","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0375090623000794/pdfft?md5=30109bf722b05d98a1079d069ad450d9&pid=1-s2.0-S0375090623000794-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42012861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de Gastroenterologia de Mexico
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1